A clinical trail to study the efficacy and safety of low molecular weight heparin (Dalteparin) in elderly Indian patients presenting with acute heart pain patients.
Phase 4
- Registration Number
- CTRI/2010/091/000473
- Lead Sponsor
- Dr.MADDURY JYOTSNA,Associate professor,DEPARTMENT OF CARDIOLOGY,NIMS,PUNJAGUTTA,HYDERABAD,A.P,INDIA-500 082
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
patients above 60 years admitted with unstable angina or non STMI admitted to cardaic care unit who does not have contraindications to anti coagulations
or
patients above 60 years who are has under gone PCI with bivalrudin periprocedurally requiring anti coagulation after procedure
Exclusion Criteria
patients who have underlying coagulation disorders,ulcer disease,maliganancy,recent surgery ,recent cerebrovascular event less than 3 months or active bleeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method